Company: IMNN
Filing Date: 2025-11-13
Form Type: S-8
Source: 0001493152-25-022140
Chunk: 0

Company: Imunon, Inc.
Filing Date: 2025-11-13
Form: S-8
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on November 13, 2025</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

IMUNON, INC.

(Exact name of registrant as specified in its charter)</div>

| Delaware                 |     | 52-1256615         |
| (State                   
 or other jurisdiction of 
 incorporation            
 or organization)         |     | -I.R.S. Employer   
 Identification No. |

<div align='center'>997 Lenox Drive, Suite 100

Lawrenceville, NJ 08648-2311

(Address of principal executive offices) (Zip code)

Imunon, Inc. 2018 Stock Incentive Plan

(Full title of the plan)

Stacy R. Lindborg

President and Chief Executive Officer

997 Lenox Drive, Suite 100

Lawrenceville, NJ 08648

(609) 896-9100

(Name, address and telephone number, including area code, of agent for service)

Copies to:

Jurgita Ashley

Thompson Hine LLP

3900 Key Center

127 Public Square

Cleveland, Ohio 44114

(216) 566-5500</div>

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large             
 accelerated filer | ☐ | Accelerated       
 filer             | ☐ |
| Non-accelerated   
 filer             | ☒ | Smaller           
 reporting company | ☒ |
|                   |   | Emerging          
 growth company    | ☐ |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

<div align='center'>EXPLANATORY NOTE</div>

On July 11, 2025, the